Dear Jill and Colleagues:
I agree with our colleagues' feedback.
For South Africa, a CPP will be required and it will have to be legalized and authenticated by the SA Consulate in the country of issuance. Consider providing a streamlined version of the CTD (filed in the US or EU) so that you are better able to manage post-approval changes without having to file post-approval filings as the review and approval process in South Africa is lengthy. Electronic submissions are not required. In my past experience, a streamlined submission, with the pertinent information, is preferable. You will need to have a responsible person (preferably a pharmacist) in-country to act as you legal representative.
For Northwest Africa, I propose you consider filing and even more abbreviated filing, also to help manage post-approval changes. You may need to inquire in your product needs to be on the country's list of Essential Medicines as the precursor to your submitting your application. Using the country's application forms and payment of fees in the local currency, as required is the best way to go. You may need someone to help you navigate the review process so that attention is given to you application once filed.
If you have a specific list of countries in which you are looking to file in, I may be able to provide you with more details. If you are able to get your product WHO Prequalified, most will put a lot of weigth on that. Link:
http://apps.who.int/prequal/ Hope this helps. Good luck.
-------------------------------------------
Carla Fiankan
Vice President
Intermune
Brisbane CA
United States
-------------------------------------------
Original Message:
Sent: 12-11-2013 11:32
From: RAJASHRI OJHA
Subject: Submission Requirements for African Countries
Hi ,
If you provide your email id then I can send you PPT and other guidances for your quick reference. My email id is rajashrio@gmail.com.
You may also browse through MCC guidelines on their HA website along with below links. http://www.kznhealth.gov.za/research/mccinfo.pdf
http://www.pharmaguideline.com/2010/10/mcc.html
http://www.doh.gov.za/show.php?id=2863
Just to share my own experience;--
Earlier we used to submit dossiers to MCC in MRF-1 format (i.e. Part I, IA, IB, IC, ID and Part II, Part III, Part IV, Part V) whereas from 2010 onwards we have started submitting dossiers in CTD format(Module-1,2,3,4,5).
The language used is English(British)
Thanks and let me know if you need more information.
-------------------------------------------
RAJASHRI OJHA PHD
COGNIZANT TECHNOLOGY SOLUTIONS
THANE
India
-------------------------------------------
Original Message:
Sent: 12-10-2013 02:55
From: Jill Sackett
Subject: Submission Requirements for African Countries
Hello,
I am seeking information on basic regulatory submission requirements for drug products for Northwest and South African countries. For example, what are the requirements in these countries regarding CTD, electronic versus paper copy, allowable languages, submission mailing addresses, etc.? Can anyone recommend any sources (preferably in English) where this information can be found?
Thank you in advance for any assistance you can provide.
-------------------------------------------
Jill Sackett
Director
Libertyville IL
United States
-------------------------------------------